Graf Acquisition
Why Robinhood?
You can watch GFOR and buy or sell other stocks, ETFs, and their options commission-free!About GFOR
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.
GFOR Key Statistics
Stock Snapshot
As of today, Graf Acquisition(GFOR) shares are valued at $0.01. The company's market cap stands at 666.1K.
Graf Acquisition(GFOR) stock opened on 2026-08-09 at —. The price climbed to — and dipped to —.
Graf Acquisition(GFOR) shares are trading with a volume of 0, against a daily average of 14.46K.
During the past year, Graf Acquisition(GFOR) stock moved between $0.00 at its lowest and $0.33 at its peak.
During the past year, Graf Acquisition(GFOR) stock moved between $0.00 at its lowest and $0.33 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.